SLC7A11 and urinary bladder cancer: MiRNA-27a down-regulation can targetedly promote SLC7A11 and regulate GSH biosynthesis, thus enhancing the resistance of bladder cancer cells to cisplatin in vitro (Qin et al., 2021).